James Shin
Stock Analyst at Deutsche Bank
(1.32)
# 3,309
Out of 4,784 analysts
20
Total ratings
44.44%
Success rate
-1.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $111.79 | +7.34% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $89.23 | +17.67% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $822.51 | +23.40% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $306.95 | -0.64% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $60.60 | -0.99% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $60.02 | -25.02% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $35.06 | +71.14% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $205.29 | -26.93% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $637.36 | +25.52% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $1.66 | +502.41% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.74 | +1,528.00% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $0.78 | +8,861.72% | 1 | Dec 12, 2022 |
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $111.79
Upside: +7.34%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $89.23
Upside: +17.67%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $822.51
Upside: +23.40%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $306.95
Upside: -0.64%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $60.60
Upside: -0.99%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $60.02
Upside: -25.02%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $35.06
Upside: +71.14%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $205.29
Upside: -26.93%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $637.36
Upside: +25.52%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.74
Upside: +1,528.00%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $0.78
Upside: +8,861.72%